Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

It boils down to which company's clinical trial results look better for treating Alzheimer's at the moment.

Better Biotech Stock: Cassava Sciences vs. Annovis Bio ↗

August 26, 2021

GameStop Continues To See Sky-High WallStreetBets Interest; AMC, BlackBerry, Alibaba, Palantir Are Other Top Trends ↗

August 25, 2021

GameStop Corp. (NYSE:GME) continued to be the most-discussed ...

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cassava Sciences, Inc. and Encourages Investors with Losses to Contact the Firm

August 25, 2021

From The Schall Law Firm

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 202.8% to settle at $46.33 on Wednesday after gaining over 11% on Tuesday. Regencell Bioscience recently...

54 Biggest Movers From Yesterday ↗

August 26, 2021

Via Benzinga

Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors

August 25, 2021

From Glancy Prongay & Murray LLP

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

CASSAVA INVESTOR ALERT

August 25, 2021

Via NewMediaWire

The Law Offices of Frank R. Cruz Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors

August 25, 2021

From The Law Offices of Frank R. Cruz

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors

August 25, 2021

From Law Offices of Howard G. Smith

Today, investors in Cassava Sciences and SAVA stock are seeing a lot of red, as investors digest a statement of concern filed yesterday.

SAVA Stock: Cassava Sciences Sinks Despite Countering Trial Data Allegations ↗

August 25, 2021

Mid-Afternoon Market Update: Dow Rises 100 Points; ScanSource Shares Surge Following Q4 Results ↗

August 25, 2021

Toward the end of trading Wednesday, the Dow traded up 0.30% to 35,470.78 while the NASDAQ rose 0.12% to 15,038.45. The S&P also rose, gaining 0.28% to 4,498.64. The U.S. has...

Via Benzinga

Topics Stocks

S&P 500, Nasdaq Extend Records on Delta Variant Decline ↗

August 25, 2021

The S&P 500 Index and Nasdaq Composite are on the rise midday, extending yesterday's record closes and nabbing fresh intraday highs.

Via Talk Markets

Topics Stocks

2 Little-Known Nasdaq Stocks Making Big Moves Wednesday ↗

August 25, 2021

Don't let these companies fly under your radar.

Shares of SAVA stock are crashing on Wednesday after allegations about Cassava Sciences' Alzheimer's disease treatment are being reviewed.

Topics Stocks

SAVA Stock: The Allegations That Have Cassava Sciences Sinking Today ↗

August 25, 2021

The Law Offices of Frank R. Cruz Announces Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors

August 25, 2021

From The Law Offices of Frank R. Cruz

Gainers Regencell Bioscience (NASDAQ:RGC) stock rose 100.19% to $30.63 during Wednesday's regular session. Regencell Bioscience's stock is trading at a volume of 8...

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 25, 2021

Via Benzinga

Mid-Day Market Update: Gold Down 1%; Locust Walk Acquisition Shares Jump ↗

August 25, 2021

Midway through trading Wednesday, the Dow traded up 0.20% to 35,435.82 while the NASDAQ rose 0.05% to 15,027.49. The S&P also rose, gaining 0.14% to 4,492.54. The U.S. has the...

Via Benzinga

Topics Stocks

36 Stocks Moving In Wednesday's Mid-Day Session ↗

August 25, 2021

Gainers Locust Walk Acquisition Corp. (NASDAQ: LWAC) shares jumped 188% to $25.34 after the company announced stockholders approved a business combination with eFFECTOR...

Via Benzinga

Here's Why Cassava Sciences Is Having a Bad Day ↗

August 25, 2021

The FDA received a citizen petition requesting a halt to clinical trials with the company's Alzheimer's disease candidate.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors

August 25, 2021

From Glancy Prongay & Murray LLP

Following the market opening Wednesday, the Dow traded up 0.07% to 35,389.32 while the NASDAQ rose 0.17% to 15,045.45. The S&P also rose, gaining 0.14% to 4,492.57. The U.S....

Mid-Morning Market Update: Markets Edge Higher; Dick's Sporting Goods Beats Q2 Views ↗

August 25, 2021

Via Benzinga

Topics Stocks

Cassava Sciences Stock Shows Promise With Simufilam Trials Drawing Near ↗

August 25, 2021

SAVA stock is up as the company announced the FDA has agreed on study protocols for Phase 3 clinical trials of Simufilam.

A shareholder firm called for the FDA to halt Cassava Sciences' studies in Alzheimer's disease, leading SAVA stock to plummet Wednesday.

Cassava Stock Plummets On Claims Of 'Data Manipulation' In Alzheimer's Testing ↗

August 25, 2021

Via Investor's Business Daily

Cassava Sciences Shares Sink With Alzheimer's Drug Mired In Controversy ↗

August 25, 2021

Neurodegenerative diseases-focused biopharma Cassava Sciences, Inc. (NASDAQ: SAVA) saw both sides of the world Tuesday. The stock rallied to close higher by 2% after it announced...

Via Benzinga

Why Cassava Sciences' Stock Is Getting Hammered Today ↗

August 25, 2021

Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading lower on negative claims that were posted online yesterday after market hours. The company issued a response to the claims...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 25, 2021

Gainers Regencell Bioscience (NASDAQ:RGC) stock increased by 25.49% to $19.2 during Wednesday's pre-market session. The company's market cap stands at $242.7...

Via Benzinga

The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug ↗

August 25, 2021

ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

21 Stocks Moving in Wednesday's Pre-Market Session ↗

August 25, 2021

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) rose 40.1% to $21.43 in pre-market trading after gaining over 11% on Tuesday. Regencell Bioscience recently reported...

Via Benzinga

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors

August 25, 2021

From Law Offices of Howard G. Smith

It would be great if Cassava Sciences' treatment for Alzheimer's disease worked, but should you pay the high price for SAVA stock? No.

Cassava Sciences Has an Admirable Goal at Too High a Price ↗

August 24, 2021